Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

ADR

5 articoli — 2009-2010

RI Pagine elettroniche ; Caso Contributivo
ADR (reazione avversa ai farmaci) da ibuprofene: descrizione di un caso

N. Sardi, P. Fusco, S. Fungi, A. D’amato, L. Besenzon

2010/10 — pag. 665-666

We report a case of a 7-year-old girl developing an haemorragic duodenitis as a consequence of the administration of a single standard dose of ibuprofen for the symptomatic treatment of an upper respiratory tract infection. The aim of the case report...

RI Farmacoriflessioni
Accesso libero
Cautele sull’uso dei FANS nei bambini

Working Group Pediatrico dell’AIFA

2010/10 — pag. 654-656

In the last few years, reports on adverse drug reactions (ADRs) to NSAIDs in paediatric age, especially to ibuprofen and ketoprofen, have remarkably increased. As to the most prescribed ibuprofen, reports (rash, rectal haemorrhage and acute kidney ...

EL Caso contributivo
ADR (reazione avversa ai farmaci) da ibuprofene: descrizione di un caso

N. Sardi, P. Fusco, S. Fungi, A. D’Amato, L. Besenzon

2010/10

We report a case of a 7-year-old girl developing an haemorragic duodenitis as a consequence of the administration of a single standard dose of ibuprofen for the symptomatic treatment of an upper respiratory tract infection. The aim of the case report...

RI Focus
Profilo epidemiologico delle ADR in pediatria

A. Clavenna, M. Bonati

2009/8 — pag. 501-507

A meta-analysis of 8 prospective studies performed in the United States and Europe in the 2001-2007 period estimated that the incidence of ADRs in hospitalised children is 10.9% and in paediatric outpatients 1.0%. The contribution of ADRs to the ho...

RI Focus
L’importanza dei case report in farmacovigilanza

M. Venegoni

2009/8 — pag. 501-507

The publication of case reports is one of the useful didactic instrument to disseminate the knowledge on many or very rare adverse reactions that physicians must know whenever they make prescriptions. Moreover, the activity of pharmacovigilance and...